+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

LTM Ltd (LTM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 44 Pages
  • August 2026
  • GlobalData
  • ID: 6262338
LTM Ltd (LTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

LTM Ltd (LTM), formerly LTIMindtree Ltd, a subsidiary of Larsen & Toubro Ltd, is a technology services and consulting company that offers enterprise systems and digital solutions. LTM offers a range of services, including data and analytics, cloud and digital infrastructure, business AI systems, cybersecurity, SAP enterprise AI, and quality engineering services. It also offers solutions such as analytics, internet of things (IoT), cloud, cognitive/artificial intelligence, automation, and enterprise solutions. The company serves banking and financial services, communication media and entertainment, energy, utilities, healthcare, hi-tech, insurance, life science, manufacturing, retail and CPG, travel, transport, and hospitality. It has business presence across the Americas, Europe, Asia-Pacific, the Middle East, and Africa. LTM is headquartered in Mumbai, Maharashtra, India.

LTM Ltd Key Recent Developments

  • Nov 17, 2025: Convatec Partners With LTIMindtree for SAP S/4HANA Transformation
  • Sep 15, 2025: NextEra Partners With ServiceNow to Accelerate Digital Transformation in the Middle East

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Lupin Ltd - Key Facts
  • Lupin Ltd - Key Employees
  • Lupin Ltd - Key Employee Biographies
  • Lupin Ltd - Major Products and Services
  • Lupin Ltd - History
  • Lupin Ltd - Company Statement
  • Lupin Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Lupin Ltd - Business Description
  • Business Segment: Others
  • Overview
  • Performance
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Geographical Segment: India
  • Performance
  • Geographical Segment: Others
  • Performance
  • Geographical Segment: USA
  • Performance
  • R&D Overview
  • Lupin Ltd - Corporate Strategy
  • Lupin Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Lupin Ltd - Strengths
  • Lupin Ltd - Weaknesses
  • Lupin Ltd - Opportunities
  • Lupin Ltd - Threats
  • Lupin Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Lupin Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jul 14, 2026: Lupin Recognized Among India’s Best Employers in the Nation-Builders Category by Great Place to Work India 2026
  • Jul 06, 2026: Lupin Named Among World’s Most Sustainable Companies by Time and Statista
  • May 28, 2026: Lupin’s Ankleshwar Facility Receives EIR from U.S. FDA
  • May 07, 2026: Lupin FY2026 And Q4 Results
  • Apr 07, 2026: Lupin Announces U.S. Approval of Dapagliflozin Tablets
  • Apr 07, 2026: Lupin Earns Great Place To Work Certification for 2026-27
  • Mar 19, 2026: Lupin Manufacturing Solutions Strategic Expansion of Peptide Manufacturing Facility at Dabhasa, India
  • Mar 14, 2026: Integrating ESG Performance into Long-Term Capital Strategy for Indian Pharma
  • Feb 27, 2026: Lupin receives EIR report with VAI classification for its Goa unit
  • Feb 26, 2026: Lupin Ranks No. 1 Globally in Pharma; Tops All Sectors in India in S&P ESG Assessment 2025
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Lupin Ltd, Key Facts
  • Lupin Ltd, Key Employees
  • Lupin Ltd, Key Employee Biographies
  • Lupin Ltd, Major Products and Services
  • Lupin Ltd, History
  • Lupin Ltd, Subsidiaries
  • Lupin Ltd, Key Competitors
  • Lupin Ltd, Ratios based on current share price
  • Lupin Ltd, Annual Ratios
  • Lupin Ltd, Interim Ratios
  • Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Lupin Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Lupin Ltd, Performance Chart (2022 - 2026)
  • Lupin Ltd, Ratio Charts
  • Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Lupin Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026